NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/25/2025
Back to search
Official data from USPTO
GILEAD TOWARD HEALTH EQUITY ONCOLOGY GRANT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
11/26/2025
Trademark type
Combined
Nice classes
36
Filing date
12/13/2022
Registration date
11/25/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/25/2025
Last transaction
11/26/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2022-08-00
First use in commerce
2022-08-00
Drawing code
3
Owner type
03
Owner location
Foster City, CA
Examiner
THOMAS,AMY E
Law office
M10
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a stylized leaf imposed over a shield, with the left side of the leaf and stem being red, and the right side of the shield and left outline of the shield being red, followed by the word "GILEAD" in dark gray after which a vertical dark gray line appears, followed by the wording "TOWARD HEALTH EQUITY" in dark gray, "ONCOLOGY GRANT" in red under it. The color white represents background and is not part of the mark.
Holders and representatives
Holders
Gilead Sciences, Inc.
Representatives
Cynthia Smuzynska GILEAD SCIENCES, INC.
Technical classification
Nice Classes
Class 36
Vienna Codes
No Vienna codes available.
Goods and services
Class 36
Providing grants to individualsorganizations and programs in the field of oncology
Publications
History of USPTO decisions and trademark events.
29 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
11/25/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
11/03/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
11/03/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
10/07/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
07/19/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/13/2024
IUAF
USE AMENDMENT FILED
06/05/2024
EISU
TEAS STATEMENT OF USE RECEIVED
06/05/2024
EX2G
SOU EXTENSION 2 GRANTED
06/05/2024
EXT2
SOU EXTENSION 2 FILED
06/05/2024
EEXT
SOU TEAS EXTENSION RECEIVED
06/05/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/14/2023
EX1G
SOU EXTENSION 1 GRANTED
12/12/2023
EXT1
SOU EXTENSION 1 FILED
12/12/2023
EEXT
SOU TEAS EXTENSION RECEIVED
12/12/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
07/04/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/09/2023
PUBO
PUBLISHED FOR OPPOSITION
05/09/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/19/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/04/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
04/04/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/04/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
04/04/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/04/2023
DOCK
ASSIGNED TO EXAMINER
03/27/2023
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
01/11/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/10/2023
NWAP
NEW APPLICATION ENTERED
12/16/2022
Continuous trademark protection
Get notified about every new filing that threatens GILEAD TOWARD HEALTH EQUITY ONCOLOGY GRANT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.